Publication | Open Access
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
127
Citations
10
References
2022
Year
Long CovidClinical TherapeuticCovid-19 PandemicBaricitinib Versus DexamethasoneClinical TrialsPharmacotherapyDouble Placebo-controlled TrialMedicineCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1